Sanofi Diabetes

Welcome to Sanofi Diabetes

Living with Diabetes can be challenging, but by managing your condition with some support, you can live well. On this website you can find many resources and support to better understand the basics on how to live and stay well with diabetes and how to have a positive start and experience with the medication that’s prescribed to you.

Toujeo® DoubleStar

(insulin glargine 300 units/mL)

Toujeo DoubleStar Pen

More

Toujeo® SoloStar®

(insulin glargine 300 units/mL)

Toujeo SoloStar Pen

More

Lantus® SoloStar®

(insulin glargine 100 units/mL)

Lantus SoloStar Pen

More

Trurapi®

(insulin aspart (100 units/mL)

Trurapi Pen

More

Reporting of side effects:

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple app Store.

Alternatively, you can report side effects to Sanofi on Tel: 0800 0902 314 or send via email to UK-drugsafety@sanofi.com. By reporting side effects, you can help provide more information on the safety of this medicine.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects that you may get. See www.mhra.gov.uk/yellowcard for how to report side effects.

MAT-GB-2101528 (v6.0)
Date of Preparation: July 2025